ALG VERSUS OKT3 PROPHYLAXIS IN RENAL-TRANSPLANT PATIENTS WITH HIGH IMMUNOLOGICAL RISK

被引：0

作者：

OSORIO, JM ^{[1
]}

BIECHY, M ^{[1
]}

OSUNA, A ^{[1
]}

MARTINEZ, E ^{[1
]}

SORIANO, C ^{[1
]}

ASENSIO, C ^{[1
]}

机构：

[1] HOSP VIRGEN NIEVES,SERV NEFROL,GRANADA,SPAIN

来源：

KIDNEY INTERNATIONAL | 1994年 / 46卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：584 / 584

页数：1

共 50 条

[31] RADIATION-THERAPY FOR RENAL-TRANSPLANT REJECTION REFRACTORY TO PULSE STEROIDS AND OKT3 [J].

RODRIGUEZ, R ;

NOYES, W ;

BELZER, F ;

KINSELLA, T .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 :311-312

[32] Efficacy of rejection prophylaxis with OKT3 in renal transplantation [J].

Opelz, G .

TRANSPLANTATION, 1995, 60 (11) :1220-1224

[33] Risk-benefit of OKT3 prophylaxis in immunologic high-risk cadaver kidney transplant recipients [J].

CognyVanWeydevelt, F ;

PrudHomme, L ;

Boucher, A ;

Dandavino, R .

TRANSPLANTATION PROCEEDINGS, 1997, 29 (7A) :S32-S34

[34] OKT3 MONOCLONAL-ANTIBODY TREATMENT IN RENAL-TRANSPLANT RECIPIENTS - CLINICAL-EXPERIENCE IN 49 PATIENTS [J].

KOVARIK, J ;

ZLABINGER, GJ ;

WOLFRAM, J ;

PECHERSTORFER, M ;

WATSCHINGER, B ;

TRAINDL, O ;

POHANKA, E ;

SONNLEITNER, A ;

ULRICH, W .

TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) :1748-1752

[35] SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL-TRANSPLANT RECIPIENT TREATED WITH OKT3 [J].

HIBBERD, PL ;

TOLKOFFRUBIN, NE ;

COSIMI, AB ;

SCHOOLEY, RT ;

ISAACSON, D ;

DORAN, M ;

DELVECCHIO, A ;

DELMONICO, FL ;

AUCHINCLOSS, H ;

RUBIN, RH .

TRANSPLANTATION, 1992, 53 (01) :68-72

[36] SELECTIVE OKT3 INDUCTION THERAPY IN ADULT CADAVERIC-DONOR RENAL-TRANSPLANT RECIPIENTS [J].

THISTLETHWAITE, JR ;

HEFFRON, TG ;

STUART, JK ;

BUCKINGHAM, M ;

STUART, FP .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (05) :28-34

[37] EFFICACY OF OKT3 IN PEDIATRIC RENAL-TRANSPLANT RESCUE FOLLOWING THE USE OF PULSE METHYL PREDNISOLONE [J].

RAJPOOT, D ;

TEJANI, A ;

BUTT, K ;

SUMRANI, N ;

SAHA, A ;

POMRANTZ, A .

PEDIATRIC RESEARCH, 1989, 25 (04) :A346-A346

[38] CLINICAL AND RENAL HISTOLOGIC PREDICTORS OF RESPONSE TO OKT3 THERAPY USING THE BANFF CLASSIFICATION IN RENAL-TRANSPLANT RECIPIENTS [J].

KUPIN, W ;

VENKAT, KK ;

MOZES, M ;

ESCOBAR, F ;

GOGGINS, M .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03) :1019-1019

[39] A PROSPECTIVE CLINICAL-TRIAL COMPARING LOW-DOSE OKT3 PROPHYLAXIS AND PREDNISOLONE CYCLOSPORINE TREATMENT IN RENAL-TRANSPLANT RECIPIENTS [J].

PARLEVLIET, KJ ;

TENBERGE, IJM ;

WILMINK, JM ;

SURACHNO, J ;

SCHELLEKENS, PTA .

KIDNEY INTERNATIONAL, 1993, 43 (04) :971-972

[40] SYMPTOMATIC CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS GIVEN EITHER MINNESOTA ANTILYMPHOBLAST GLOBULIN (MALG) OR OKT3 FOR REJECTION PROPHYLAXIS [J].

BAILEY, TC ;

POWDERLY, WG ;

STORCH, GA ;

MILLER, SB ;

DUNKEL, JD ;

WOODWARD, RS ;

SPITZNAGEL, E ;

HANTO, DW ;

DUNAGAN, WC .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (02) :196-201

← 1 2 3 4 5 →